End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
10.72
CNY
|
0.00%
|
|
-3.42%
|
-7.75%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,757
|
1,641
|
1,961
|
3,496
|
2,922
|
2,499
|
Enterprise Value (EV)
1 |
1,764
|
1,544
|
1,841
|
3,300
|
2,437
|
1,979
|
P/E ratio
|
38.1
x
|
50.7
x
|
30.1
x
|
18.9
x
|
10.9
x
|
38.7
x
|
Yield
|
1.22%
|
0.66%
|
1.1%
|
0.92%
|
1.47%
|
-
|
Capitalization / Revenue
|
1.7
x
|
1.58
x
|
1.75
x
|
1.71
x
|
1.08
x
|
1.18
x
|
EV / Revenue
|
1.7
x
|
1.49
x
|
1.64
x
|
1.61
x
|
0.9
x
|
0.94
x
|
EV / EBITDA
|
17.4
x
|
17.2
x
|
16.2
x
|
12
x
|
5.4
x
|
14.3
x
|
EV / FCF
|
126
x
|
11.7
x
|
34.4
x
|
41.6
x
|
7.21
x
|
9.25
x
|
FCF Yield
|
0.8%
|
8.56%
|
2.9%
|
2.4%
|
13.9%
|
10.8%
|
Price to Book
|
2.54
x
|
2.33
x
|
2.59
x
|
3.8
x
|
2.52
x
|
2.11
x
|
Nbr of stocks (in thousands)
|
215,020
|
215,020
|
215,020
|
215,020
|
215,020
|
215,020
|
Reference price
2 |
8.170
|
7.630
|
9.120
|
16.26
|
13.59
|
11.62
|
Announcement Date
|
3/25/19
|
2/28/20
|
3/22/21
|
3/21/22
|
3/27/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,036
|
1,038
|
1,122
|
2,047
|
2,714
|
2,111
|
EBITDA
1 |
101.1
|
90.03
|
113.7
|
274.3
|
451.1
|
138.3
|
EBIT
1 |
51.39
|
43.32
|
67.25
|
224.6
|
399.5
|
73.31
|
Operating Margin
|
4.96%
|
4.17%
|
5.99%
|
10.97%
|
14.72%
|
3.47%
|
Earnings before Tax (EBT)
1 |
46.39
|
36.74
|
75.48
|
218.6
|
402.1
|
51.47
|
Net income
1 |
46.1
|
32.38
|
65.11
|
185.3
|
268.2
|
64.5
|
Net margin
|
4.45%
|
3.12%
|
5.8%
|
9.05%
|
9.88%
|
3.06%
|
EPS
2 |
0.2144
|
0.1506
|
0.3028
|
0.8617
|
1.247
|
0.3000
|
Free Cash Flow
1 |
14.03
|
132.2
|
53.45
|
79.35
|
338.2
|
214
|
FCF margin
|
1.35%
|
12.74%
|
4.76%
|
3.88%
|
12.46%
|
10.14%
|
FCF Conversion (EBITDA)
|
13.88%
|
146.89%
|
47.01%
|
28.93%
|
74.98%
|
154.75%
|
FCF Conversion (Net income)
|
30.44%
|
408.36%
|
82.09%
|
42.83%
|
126.11%
|
331.83%
|
Dividend per Share
2 |
0.1000
|
0.0500
|
0.1000
|
0.1500
|
0.2000
|
-
|
Announcement Date
|
3/25/19
|
2/28/20
|
3/22/21
|
3/21/22
|
3/27/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
7.14
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
96.4
|
120
|
196
|
485
|
519
|
Leverage (Debt/EBITDA)
|
0.0706
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
14
|
132
|
53.4
|
79.4
|
338
|
214
|
ROE (net income / shareholders' equity)
|
6.12%
|
4.86%
|
9.29%
|
22.7%
|
31.3%
|
4.11%
|
ROA (Net income/ Total Assets)
|
3.37%
|
2.98%
|
4.37%
|
11.7%
|
15.2%
|
2.34%
|
Assets
1 |
1,367
|
1,088
|
1,490
|
1,581
|
1,767
|
2,761
|
Book Value Per Share
2 |
3.220
|
3.270
|
3.520
|
4.270
|
5.390
|
5.500
|
Cash Flow per Share
2 |
0.2100
|
0.4700
|
0.6200
|
1.040
|
2.350
|
2.650
|
Capex
1 |
5.46
|
1.65
|
5.13
|
13.6
|
54.1
|
12.3
|
Capex / Sales
|
0.53%
|
0.16%
|
0.46%
|
0.66%
|
1.99%
|
0.58%
|
Announcement Date
|
3/25/19
|
2/28/20
|
3/22/21
|
3/21/22
|
3/27/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| -7.75% | 318M | | +3.47% | 103B | | -8.74% | 61.43B | | +72.86% | 49.09B | | +15.48% | 38.46B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +12.53% | 16.78B | | +15.34% | 14.76B | | +0.39% | 13.73B |
Other Commodity Chemicals
|